tiprankstipranks
Trending News
More News >
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Income Statement

Compare
214 Followers

Senti Biosciences Income Statement

Last quarter (Q3 2025), Senti Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Senti Biosciences's net income was $-18.13M. See Senti Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.98M$ 3.29M$ 2.29M$ 394.00K
Gross Profit
$ 0.00$ 1.98M$ 3.29M$ 2.29M$ 394.00K
Operating Expenses
$ 61.04M$ 94.70M$ 65.37M$ 42.74M$ 25.09M
Depreciation and Amortization
$ 5.85M$ 5.43M$ 3.92M$ 3.01M$ 1.99M
EBITDA
$ -54.88M$ -61.34M$ -58.16M$ -37.44M$ -22.71M
Operating Income
$ -61.04M$ -92.73M$ -62.08M$ -40.45M$ -24.69M
Other Income/Expenses
$ 8.25M$ 9.32M$ 12.42M$ -14.87M$ 4.83M
Pretax Income
$ -52.79M$ -83.41M$ -49.66M$ -55.32M$ -19.86M
Net Income
$ -52.79M$ -71.06M$ -58.21M$ -55.32M$ -19.86M
Per Share Metrics
Basic EPS
$ -11.49$ -20.94$ -13.25$ -12.67$ -4.55
Diluted EPS
$ -11.49$ -20.94$ -13.25$ -12.67$ -4.55
Weighted Average Shares Outstanding
4.60M 4.44M 4.39M 4.37M 4.37M
Weighted Average Shares Outstanding (Diluted)
4.60M 4.44M 4.39M 4.37M 4.37M
Currency in USD

Senti Biosciences Earnings and Revenue History